Bladder Cancer
Cost-effectiveness analysis of different treatment modalities in BCG-unresponsive NMIBC.
March 19, 2024
Addition of neoadjuvant chemotherapy to a 'quadrifecta' composite in radical cystectomy.
March 18, 2024
Characterization of Targets for Antibody-Drug Conjugates in Advanced Urothelial Carcinoma - Expert Commentary
March 15, 2024
Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers.
March 15, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancer.
March 14, 2024
Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
March 14, 2024
Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
March 14, 2024
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial in patients with bladder cancer.
March 13, 2024
Cost-Utility of Initial Management of High-grade T1 Bladder Cancer with Intravesical BCG vs Immediate Radical Cystectomy.
March 13, 2024
Prognostic Value of Fibroblast Growth Factor Receptor Genetic Alterations in Metastatic Urothelial Carcinoma.
March 12, 2024
The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US Veterans Health Administration Study.
March 12, 2024